Bernard Ravina - 22 Jun 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Reporting relationship: Chief Medical Officer
Issuer ticker: PRAX
Reported as of: 22 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jun 2022, 16:47:04 UTC
Prior SEC filing: 15 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Alex Nemiroff, as Attorney-in-Fact

Key filing fact

Bernard Ravina filed Form 4 for Praxis Precision Medicines, Inc. (PRAX) on 24 Jun 2022.

Key facts

This page summarizes Bernard Ravina's Form 4 filing for Praxis Precision Medicines, Inc. (PRAX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2022, 16:47.

Change

Previous filing in this sequence was filed on 15 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +65,000
Change %
Price: $0.000000
Shares after: 65,000
Date: 22 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $2.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.